Our province intends to develop new anti-radioactive drugs (Fujian Daily)



News from our newspaper (Reporter Xu Zhansheng and intern Lin Na) On the 25th, Fujian Province Mindong Lijiexun Pharmaceutical, the First Affiliated Hospital of Fujian Medical University and Professor Zhang Lurong of Fujian Medical University signed a contract in Fuzhou, preparing to develop anti-radiation Fibrosis A new drug for cooperation.
radiotherapy is currently the main means of treatment of lung cancer, nasopharyngeal carcinoma and other tumors. Professor Zhang Lurong discovered a low-toxic small molecule compound with clinical treatment prospects for radiation-induced pulmonary fibrosis in his research and obtained a patent. According to reports, the successful listing of the drug will have great clinical significance for the prevention and treatment of pulmonary fibrosis in China and the world.